Methods: 80 patients were included in this study, who were diagnosed with carcinoma breast and underwent surgery followed by receptor status analysis. This is a retrospective study wherein the receptor status of these patients were analysed to assess the incidence and type of receptor involved. Receptors studied include ER, PR and Her 2neu. Result: from the above study it was concluded that, the percentage of patients with ER+/PR+ were 41.3%, ER+/PR-were 1.3%, ER-/PR+ were 1.3%, ER-/PR- were 53.8% and percentage of Her2neu positive were 8.8% while Her2neu negative were 91.3%. Percentage of patients with triple negative receptor status was 62.5%. Conclusion: from this study it can be concluded that most patients presenting to our hospital have ER, PR and Her 2neu NEGATIVE STATUS which has a poor prognosis and high mortality.